Alain Kuyumjian
Advises clients on public and private capital markets debt and equity transactions. Also provides general corporate advice to U.S. and Latin American companies.
Alain advises clients on public and private capital markets debt and equity transactions, including initial public offerings, high-yield and investment-grade debt offerings, sovereign debt offerings and liability management transactions. His work spans a range of industries, including financial services, biotech, industrials and consumer products.
He also advises corporate clients, primarily based in the United States and Latin America, on general corporate matters, including corporate governance and securities law compliance.
Experience
Alainβs representative transactions include:
- The initial public offerings of Applied Therapeutics, ATAI Life Sciences, Biodesix, CureVac, Cynapsus Therapeutics, FTAC Hera, GraΓ±a y Montero, Kala Pharmaceuticals, Prime Medicine and RE/MAX
- CMPCβs sustainability-linked notes offering and Sociedad QuΓmica y Minera de Chileβs green bonds
- ATM programs for Applied Therapeutics and Biodesix
- Government of Belize marine conservation-linked debt restructuring
- Rights offerings by Enersis, Sociedad QuΓmica y Minera de Chile and ItaΓΊ Corpbanca
- Canadian National Railway, Entel, Euronet Worldwide and Industrias PeΓ±oles debt offerings
- Banco Santanderβs concurrent exchange offers in the United States and Mexico to acquire up to 25% of Santander Mexico
- Alseaβs equity follow-on financing for the Vips acquisition
- Santander Mexicoβs global equity offering and listing on the NYSE and debt financings
Insights
Recognition
Latinvex β βLatin Americaβs Rising Legal Stars,β 2015
Education
- with great distinction
- Editor, McGill Law Journal
Clerkships
Qualifications and admissions
- Province of Ontario
- State of New York